Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4446089
Max Phase: Preclinical
Molecular Formula: C47H81N3O15
Molecular Weight: 928.17
Molecule Type: Unknown
Associated Items:
ID: ALA4446089
Max Phase: Preclinical
Molecular Formula: C47H81N3O15
Molecular Weight: 928.17
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC[C@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N(C)C)[C@H]2O)[C@@H](C[C@H](C(=O)NC(C)(C)C)N(C)C(C)=O)C[C@@H](C)C(=O)/C=C/C(C)=C/[C@@H]1CO[C@H]1O[C@@H](C)[C@H](O)[C@H](OC)[C@@H]1OC
Standard InChI: InChI=1S/C47H81N3O15/c1-16-35-31(23-61-46-43(60-15)42(59-14)39(56)28(6)63-46)19-24(2)17-18-33(52)25(3)20-30(21-32(50(13)29(7)51)44(58)48-47(8,9)10)41(26(4)34(53)22-36(54)64-35)65-45-40(57)37(49(11)12)38(55)27(5)62-45/h17-19,25-28,30-32,34-35,37-43,45-46,53,55-57H,16,20-23H2,1-15H3,(H,48,58)/b18-17+,24-19+/t25-,26+,27-,28+,30-,31-,32-,34-,35-,37+,38-,39+,40-,41-,42+,43+,45+,46+/m1/s1
Standard InChI Key: VFBTWLMMHOSSBV-JDSZTGABSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 928.17 | Molecular Weight (Monoisotopic): 927.5668 | AlogP: 2.13 | #Rotatable Bonds: 13 |
Polar Surface Area: 232.32 | Molecular Species: NEUTRAL | HBA: 16 | HBD: 5 |
#RO5 Violations: 2 | HBA (Lipinski): 18 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 12.54 | CX Basic pKa: 7.94 | CX LogP: 2.00 | CX LogD: 1.35 |
Aromatic Rings: 0 | Heavy Atoms: 65 | QED Weighted: 0.17 | Np Likeness Score: 1.27 |
1. Budragchaa T, Westermann B, Wessjohann LA.. (2019) Multicomponent synthesis of α-acylamino and α-acyloxy amide derivatives of desmycosin and their activity against gram-negative bacteria., 27 (15): [PMID:31229422] [10.1016/j.bmc.2019.05.046] |
Source(1):